Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph A Tangrea

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Cancer Causes & Control : CCC|August 30, 2003
Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States)Joseph A Tangrea, Paul S Albert, Elaine Lanza, et al.
Cancer Causes & Control : CCC|July 31, 2002
Adenomatous polyp recurrence and physical activity in the Polyp Prevention Trial (United States)Lisa H Colbert, Elaine Lanza, Rachael Ballard-Barbash, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 12, 2014
A randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiologyKenneth G Linden, Sancy A Leachman, Jonathan S Zager, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Cancer Causes & Control : CCC|August 30, 2003
Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States)Joseph A Tangrea, Paul S Albert, Elaine Lanza, et al.
Cancer Causes & Control : CCC|July 31, 2002
Adenomatous polyp recurrence and physical activity in the Polyp Prevention Trial (United States)Lisa H Colbert, Elaine Lanza, Rachael Ballard-Barbash, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 12, 2014
A randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiologyKenneth G Linden, Sancy A Leachman, Jonathan S Zager, et al.
Pageof 3